Skip to content

Depression: all studies

Page 530 of 1,037: studies 5,291 to 5,300 of 10,363, newest first. Back to the depression overview

Research

Internalisasi Maqam Syukur Dalam Tasawuf

JURNAL SYIAR-SYIAR December 20, 2025 Dewi Adawiah, Solihah Sari Rahayu, Jamaludin Jamaludin

Contemporary psychological crises, driven by overwhelming productivity demands and existential meaninglessness, reveal the inadequacy of materialistic therapeutic approaches in addressing profound mental health challenges. This investigation examines gratitude as a conceptual bridge connecting positive psychology frameworks with Sufi spiritual traditions, proposing comprehensive therapeutic...

Mindfulness-based stress reduction for sexual psychological recovery after radical cervical cancer surgery: A retrospective study.

World Journal of Psychiatry December 19, 2025 Qin-Qin Sun, Fei-Fei Ke, Hong-You Zhou et al.

Patients who undergo radical cervical cancer surgery often experience sexual dysfunction and psychological distress, which seriously affects their quality of life. This study aimed to evaluate the clinical effectiveness of mindfulness-based stress reduction (MBSR) therapy for psychosexual adaptation in patients after radical cervical cancer surgery. To systematically evaluate the clinical...

DOI: 10.5498/wjp.v15.i12.112655 (opens in new tab) Full text (opens in new tab) Anxiety and depression Cervical cancer Psychosexual adaptation Radical surgery +3

Effects of LSD and Psilocybin on Heart Rate in Patients Receiving Psychedelic Treatment for Depressive and Anxiety Disorders: A Retrospective Observational Study

Psychology International December 19, 2025 Morgan C H Cheng, Tatiana Aboulafia Brakha, Albert Buchard et al.

Classic psychedelics such as lysergic acid diethylamide (LSD) and psilocybin induce mild cardiovascular activation in addition to their psychological effects. While these effects are well described in healthy adults, little is known about their dynamics in clinical populations undergoing psychedelic-assisted psychotherapy. This retrospective, observational, single-center study analyzed...

Psilocybin-assisted therapy for individuals with palliative care needs: A systematic review of safety and efficacy

Palliative Medicine December 18, 2025 Rita S. Matos, A. C. Silva, Licínio Rego et al. 1 citation

Background: Palliative Care is concerned with relieving suffering and improving the quality of life of patients and their families. Currently, questions arise about how to provide patients with good end-of-life care. There has been increasing interest in the beneficial effects of using psilocybin-assisted therapy in patients with severe chronic illnesses near the end of their lives and who...

DOI: 10.1177/02692163251383335 (opens in new tab) Anxiety Palliative care Health care Medline +4

Is ibogaine treatment durable? 12-month follow-up of magnesium–ibogaine therapy (MISTIC) in Special Operations Veterans with traumatic brain injuries

Research Square December 17, 2025 Camarin E. Rolle, Nolan Williams, Afik Faerman et al. preprint

Abstract Traumatic brain injury (TBI) can result in chronic functional disability and is associated with persistent psychiatric symptoms, including posttraumatic stress disorder (PTSD), depression, and anxiety. Ibogaine, an oneirogenic alkaloid with unique pharmacological properties, has shown initial promise as a potential treatment for TBI-related sequelae. We previously observed large...

DOI: 10.21203/rs.3.rs-6909189/v1 (opens in new tab) Full text (opens in new tab) Anxiety disorder Randomized controlled trial Clinical trial Poison control +5

Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia’s clinical landscape

Australian & New Zealand Journal of Psychiatry December 17, 2025 Megan Dutton, Paul Schwenn, Jules S Mitchell et al. 1 citation

Australia’s reclassification of psilocybin as a Schedule 8 substance for treatment-resistant depression represents a significant shift in psychiatric policy. While this regulatory change positions Australia as a global leader in psychedelic medicine, its implementation has revealed substantial challenges. This article critically examines the regulatory, ethical and operational complexities...

DOI: 10.1177/00048674251398677 (opens in new tab) Psilocybin Mental health Context archaeology Novelty +6

The effectiveness of mindfulness as a complementary therapy in headache patients: a preliminary interventional study

Confinia Cephalalgica December 16, 2025 Emanuela Principe, Melissa Pirrotta, Nicola Fava et al.

Background: Recent studies have highlighted that mindfulness-based therapies, particularly the Mindfulness-Based Stress Reduction (MBSR) program, can help foster greater awareness and improve the management of stress and chronic pain. Mindfulness is defined as a form of awareness that is intentionally cultivated in the present moment, characterized by an attitude of openness and non-judgment....

DOI: 10.4081/cc.2025.15788 (opens in new tab) Anxiety Intervention counseling Mindfulness-based stress reduction Chronic pain +11

Neuroprotective and anxiolytic effects of Matricaria chamomilla ethanolic extract against harmine-induced anxiety and oxidative stress in rats exposed to forced swimming stress

Archives of Biological Sciences December 16, 2025 Hamida Youcef Islam, Chouba Ibtissem, Habbachi Wafa

The global rise in anxiety and depression disorders has drawn attention to compounds like harmine, a Peganum harmala alkaloid, which induces a pronounced anxiety response. Herbal treatments exhibit the potential to relieve such symptoms with minimal or no side effects. This study aimed to investigate the behavioral, neurobiological, and protective effects of the ethanolic extract of Matricaria...

DOI: 10.2298/abs251001032h (opens in new tab) Full text (opens in new tab) Harmine Ethanolic extract Anxiety disorders Adrenocorticotropic hormone acth +1

Preadministration of Lorazepam Negates the Long-Term Antidepressant-Like Effects of Psilocybin in Male Wistar Kyoto Rats

Psychedelic Medicine December 16, 2025 Sophie Woodruff, Meghan Hibicke, Charles D. Nichols

Introduction:Psilocybin, a classical psychedelic, has shown to produce persistent antidepressant effects, including in patients with treatment-resistant depression. In clinical practice, it is common to coprescribe benzodiazepines (BZDs) alongside antidepressants. However, our preliminary study indicated that preadministration of lorazepam diminished the antidepressant-like efficacy and...

DOI: 10.1177/28314425251393186 (opens in new tab) Psilocybin Lorazepam Pharmacology Prefrontal cortex +6

Psychedelic-Assisted Therapy (Pat): A New Frontier in Mental Health Treatment

˜The œjournal of desk research review and analysis. December 16, 2025 M. H. M. Wickramasekara, G. D. M. C. Gonapaladeniya

Psychedelic-assisted therapy (PAT) has emerged as a promising and innovative approach to treating a range of mental health disorders, including depression, post-traumatic stress disorder (PTSD), and substance use disorders. Once sidelined due to regulatory bans and social stigma, psychedelics such as psilocybin, 3,4-methylenedioxymethamphetamine (MDMA), lysergic acid diethylamide (LSD), and...